Skip to Content

Dapsone Pregnancy and Breastfeeding Warnings

Medically reviewed on November 20, 2017

Dapsone Pregnancy Warnings

Dapsone has been assigned to pregnancy category C. There are no animal data or controlled data in human pregnancies. Experience with dapsone during all trimesters of human pregnancy has not indicated an increased risk of fetal abnormalities. Dapsone should only be given during pregnancy when benefit outweighs risk.

See references

Dapsone Breastfeeding Warnings

Dapsone is excreted into human milk. Hemolytic reactions have been reported in neonates. Due to the potential for serious adverse effects in a nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into consideration the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Dapsone USP (dapsone)." Jacobus Pharmaceutical Company, Princeton, NJ.

References for breastfeeding information

  1. Sanders SW, Zone JJ, Foltz RL, et al "Hemolytic anemia induced by dapsone transmitted through breast milk." Ann Intern Med 96 (1982): 465-6
  2. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  3. "Product Information. Dapsone USP (dapsone)." Jacobus Pharmaceutical Company, Princeton, NJ.
  4. Edstein MD, Veenendaal JR, Newman K, Hyslop R "Excretion of chloroquine, dapsone and pyrimethamine in human milk." Br J Clin Pharmacol 22 (1986): 733-5

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide